Filing Flows › Globus Medical (GMED) › Q2 2026
Globus Medical (GMED) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 6, 2026
Globus Medical (GMED) reported revenue of $790M for the second quarter 2026 (Q2 2026), +6% from a year earlier and +4% from the quarter before. Operating margin was 23.1%, net earnings $152M (19.2% of revenue).
Globus Medical, Q2 2026: revenue $790M (+6% year over year), operating margin 23.1%, net earnings $152M, operating cash flow $210M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $790M | +4% | +6% |
| Operating profit | $182M | +21% | +140% |
| Net earnings | $152M | +22% | -25% |
| Operating cash flow | $210M | +4% | +169% |
| Free cash flow | $177M | — | +464% |
What changed
Revenue was $789.6M in Q2 2026, up 6% year over year and up 4% from the previous quarter. Musculoskeletal Solutions was the largest line at 97% of revenue. Musculoskeletal Solutions added $53.4M year over year (up 8%), 121% of the total change. Enabling Technologies declined 26%.
Operating profit was $182.4M, a 23.1% margin (up 12.9 points year over year). Of the extra revenue versus Q2 2025, 240% reached operating profit, above the 10% margin then. Total costs fell 9% while revenue rose 6%. Net earnings were $151.6M, down 25% year over year. The effective tax rate was 20.1%.
Operating cash flow was $209.7M (up 169% year over year), 138% of net earnings. Non-cash charges added back $69.5M of depreciation and amortization and $13.4M of share-based compensation. Working capital and other items used $24.7M. After purchases of property and equipment ($33.2M), free cash flow as the company reports it was $176.6M.
Questions
What was Globus Medical's revenue in the second quarter 2026?
Globus Medical (GMED) reported revenue of $790M for the second quarter 2026 (Q2 2026), +6% from a year earlier and +4% from the quarter before.
Was Globus Medical profitable in the second quarter 2026?
Operating profit was $182M (23.1% of revenue) and net earnings $152M.
Source: Globus Medical 10-Q on SEC EDGAR.